$100B Pfizer Tie-Up Plan Puts Focus On US Corporate Exodus
Pfizer Inc. this week outlined a prospective $100 billion merger with British rival AstraZeneca PLC that could suck billions of tax dollars out of the U.S., shining a brighter spotlight on...To view the full article, register now.
Already a subscriber? Click here to view full article